Actinobac Biomed
Kendall Park, US · New Jersey corporation
Founders & leadership
BB
BENJAMIN BELINKANamed on SEC filing
JG
JAMES GOLUBIESKINamed on SEC filing
PA
PETER ALFFNamed on SEC filing
SK
SCOTT KACHLANYNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$3.4M disclosed across 2 rounds · 2017–2018
▶$1MraisedJun 2018 · 1 investors · PharmaceuticalsRule 506(b)
▶$1MraisedJun 2018 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Scott KachlanyDirector
- Peter AlffDirector
- James GolubieskiDirector
- Benjamin Belinka, Jr.Executive Officer, Director
- Offering amount
- $6M
- Amount sold
- $1M
- First sale
- May 2018
- Incorporated
- Corporation, New Jersey
- Federal exemptions
- 06b
▶$2.4MraisedJul 2017 · 1 investors · PharmaceuticalsRule 506(b)
▶$2.4MraisedJul 2017 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- BENJAMIN BELINKAExecutive Officer, Director
- JAMES GOLUBIESKIDirector
- PETER ALFFDirector
- SCOTT KACHLANYDirector
- Offering amount
- $2.4M
- Amount sold
- $2.4M
- First sale
- Jul 2017
- Incorporated
- Corporation, New Jersey
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Actinobac Biomed raised?
- Actinobac Biomed has disclosed $3.4M raised across 2 rounds.
- Where is Actinobac Biomed headquartered?
- Actinobac Biomed is headquartered in Kendall Park, US.